Quantitative Systematic Strategies LLC Repligen Corp Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 06, 2021
BUY
$180.37 - $226.26 $31,564 - $39,595
175 Added 11.08%
1,755 $341,000
Q4 2020

Feb 09, 2021
SELL
$148.08 - $206.57 $11,550 - $16,112
-78 Reduced 4.7%
1,580 $303,000
Q3 2020

Nov 09, 2020
SELL
$122.51 - $158.27 $7,350 - $9,496
-60 Reduced 3.49%
1,658 $245,000
Q2 2020

Aug 04, 2020
BUY
$94.33 - $140.48 $162,058 - $241,344
1,718 New
1,718 $212,000
Q1 2020

May 06, 2020
SELL
$84.96 - $109.14 $579,852 - $744,880
-6,825 Closed
0 $0
Q4 2019

Feb 11, 2020
BUY
$73.84 - $93.08 $503,958 - $635,271
6,825 New
6,825 $631,000

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email